<DOC>
	<DOCNO>NCT01949077</DOCNO>
	<brief_summary>The purpose study determine difference level serum chemokines patient undergo treatment Boceprevir . The aim determine non-responders significantly different level chemokines responder .</brief_summary>
	<brief_title>Evaluation Serum Chemokines Patients Undergoing Treatment With Boceprevir .</brief_title>
	<detailed_description>Patients undergo standard care UNC Liver Center consent collection additional serum sample UNC Liver Center serum tissue bank study . These sample use analyze difference serum chemokines across responder non-responders .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>All adult patient ( age 18 old ) treat antiviral Hepatitis C treatment regimen include Boceprevir . Inability provide inform consent serum sample enrol University North Carolina Liver Center serum bank . No pre post serum sample available within 6 month treatment period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Hepatitis</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Observational study</keyword>
	<keyword>Biomarkers treatment response</keyword>
</DOC>